Figures & data
Table 1 Targeted agents for the treatment of CLL
Figure 1 Mechanisms of action of anti-CD20 monoclonal antibodies.
![Figure 1 Mechanisms of action of anti-CD20 monoclonal antibodies.](/cms/asset/63aac2a3-67f5-4547-9ef2-4616ef2f20cf/dpgp_a_55501_f0001_b.jpg)
Table 2 Comparison of commercially available anti-CD20 antibodies
Table 3 Comparison of patient characteristics, efficacy, and toxicity of anti-CD20 antibody–chlorambucil combinations from CLL11 study